Consolidated Balance Sheets - USD ($)
|
Sep. 30, 2015 |
Dec. 31, 2014 |
Dec. 31, 2013 |
| Current Assets |
|
|
|
| Cash and cash equivalents |
$ 8,210,938
|
$ 3,714,304
|
$ 4,566,992
|
| Investments, held to maturity (net) |
6,742,987
|
10,698,982
|
17,297,165
|
| Prepaid expenses and other current assets |
986,264
|
863,227
|
1,066,638
|
| Total Current Assets |
15,940,189
|
15,276,513
|
22,930,795
|
| Property and Equipment, net |
467,999
|
445,534
|
53,753
|
| Other Assets |
|
|
|
| Restricted cash |
101,146
|
101,129
|
1,252
|
| Deposits |
69,798
|
19,798
|
9,320
|
| Related party receivable |
58,017
|
48,642
|
$ 24,946
|
| Deferred financing costs, net |
25,379
|
24,554
|
|
| Total Other Assets |
254,340
|
194,123
|
$ 35,518
|
| Total Assets |
16,662,528
|
15,916,170
|
23,020,066
|
| Current Liabilities |
|
|
|
| Accounts payable |
936,361
|
1,367,426
|
651,917
|
| Accrued expenses and other payables |
2,074,174
|
$ 805,968
|
503,050
|
| Accrued interest |
|
|
$ 25,364
|
| Current portion of long term debt |
2,053,859
|
$ 397,465
|
|
| Total Current Liabilities |
5,064,394
|
2,570,859
|
$ 1,180,331
|
| Long Term Liabilities |
|
|
|
| Long term debt, net of discount and current portion |
2,831,787
|
$ 2,314,124
|
|
| Other long term liabilities |
12,228
|
|
$ 122,590
|
| Total Liabilities |
$ 7,908,409
|
$ 4,884,983
|
$ 1,302,921
|
| Commitments and Contingencies |
|
|
|
| Stockholders' Equity |
|
|
|
| Common stock, $.0002 par value; 50,000,000 shares authorized, 8,415,434 and 6,492,622 shares issued and outstanding at September 30, 2015 (unaudited) and December 31, 2014, respectively |
$ 1,365
|
$ 982
|
$ 961
|
| Additional paid in capital |
48,038,935
|
35,894,823
|
34,337,591
|
| Accumulated deficit |
(37,943,582)
|
$ (24,135,447)
|
(12,346,630)
|
| Accumulated other comprehensive loss |
(64,238)
|
|
|
| Total Stockholders' Equity- Less Non-Controlling Interest |
10,032,480
|
$ 11,760,358
|
21,991,922
|
| Non-Controlling Interest |
(1,278,361)
|
(729,171)
|
(274,777)
|
| Total Stockholders' Equity - Heat Biologics, Inc. |
8,754,119
|
11,031,187
|
21,717,145
|
| Total Liabilities and Stockholders' Equity |
$ 16,662,528
|
$ 15,916,170
|
$ 23,020,066
|
| Series 1 Preferred Stock [Member] |
|
|
|
| Stockholders' Equity |
|
|
|
| Total Stockholders' Equity - Heat Biologics, Inc. |
|
|
|
| Series A Preferred Stock [Member] |
|
|
|
| Stockholders' Equity |
|
|
|
| Total Stockholders' Equity - Heat Biologics, Inc. |
|
|
|
| Series B-1 Preferred Stock [Member] |
|
|
|
| Stockholders' Equity |
|
|
|
| Total Stockholders' Equity - Heat Biologics, Inc. |
|
|
|